Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Oct 2026 for AN2 Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Gilbert Lynn Marks: trading record in brief
Gilbert Lynn Marks appears in our data through filings on AN2 Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 19 December 2024 to 12 October 2026, the count stands at 8 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 13 October 2026: a share grant, in AN2 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gilbert Lynn Marks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,283 shares0Common StockSEC:0001193125-26-420643:0
2,789 shares0Common StockSEC:0001193125-26-301166:0
3,775 shares0Common StockSEC:0001193125-26-151628:0
11,560 shares0Common StockSEC:0001193125-26-013035:0
10,367 shares0Common StockSEC:0001193125-25-238984:0
11,875 shares0Common StockSEC:0000950170-25-095406:0
9,705 shares0Common StockSEC:0000950170-25-053348:0
8,972 shares0Common StockSEC:0000950170-24-139797:0
8 of 8 declarations
